Bernard G. Francq
Bernard G. Francq has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Nikolaos Giannelos
GSK, Wavre, Belgium
2 shared publications - Aaron Hieb
Genentech, Pharmaceutical Development, 1 DNA Way, South San Francisco, CA 94080
1 shared publication Adam Palmer Rauk
Development Statistics, Eli Lilly and Company, Lilly Corporate Center, 893 Delaware St, Indianapolis, IN 46225, USA
1 shared publicationAmy St. Charles
Pfizer, Inc., Analytical Research & Development, 875 Chesterfield Parkway West, Chesterfield, MO 63017, USA
1 shared publicationAndrea Ji
Genentech, Pharmaceutical Development, 1 DNA Way, South San Francisco, CA 94080
1 shared publicationArmin Boehrer
Boehringer Ingelheim Pharma GmbH & Co. KG, Global Development CMC Biologicals, 88397 Biberach/Riss, Germany
1 shared publication
Latest Publications
- 4 September 2026
- Published by Wiley in Pharmaceutical Statistics
- Vol. 25 (5) , e70116
Accelerated Stability Studies: A Frequentist–Bayesian Hybrid Simulation Approach Implemented in the AccelStab R Package
Stability assessment of vaccine drug products typically requires years of data collection. Accelerated stability studies offer a practical alternative by leveraging high‐temperature data collected over shorter time periods. We model degradation using arbitrary n th order kinetics and derive a closed‐form solution that enables extrapolation across time and temperature. We compare interval estimation methods including the delta method, bootstrap resampling, and Bayesian inference and propose a frequentist–Bayesian hybrid (FBH) posterior approximation framework based on a multivariate Student's t ‐distribution. FBH is closely related to objective Bayesian inference under noninformative priors in simple Gaussian settings and fully propagates uncertainty in both model parameters and residual variance. Simulation results show that FBH outperforms standard approaches by consistently achieving nominal coverage, particularly in small‐sample settings where competing methods exhibit undercoverage. The approach provides well‐calibrated confidence and prediction intervals while maintaining computational efficiency comparable to analytical methods and avoiding the cost of full posterior sampling. The methodology is illustrated using two vaccine development case studies and implemented in the AccelStab R package.
- 4 September 2026
- Published by Wiley in Pharmaceutical Statistics
- Vol. 25 (5) , e70116
Accelerated Stability Studies: A Frequentist–Bayesian Hybrid Simulation Approach Implemented in the AccelStab R Package
Stability assessment of vaccine drug products typically requires years of data collection. Accelerated stability studies offer a practical alternative by leveraging high‐temperature data collected over shorter time periods. We model degradation using arbitrary n th order kinetics and derive a closed‐form solution that enables extrapolation across time and temperature. We compare interval estimation methods including the delta method, bootstrap resampling, and Bayesian inference and propose a frequentist–Bayesian hybrid (FBH) posterior approximation framework based on a multivariate Student's t ‐distribution. FBH is closely related to objective Bayesian inference under noninformative priors in simple Gaussian settings and fully propagates uncertainty in both model parameters and residual variance. Simulation results show that FBH outperforms standard approaches by consistently achieving nominal coverage, particularly in small‐sample settings where competing methods exhibit undercoverage. The approach provides well‐calibrated confidence and prediction intervals while maintaining computational efficiency comparable to analytical methods and avoiding the cost of full posterior sampling. The methodology is illustrated using two vaccine development case studies and implemented in the AccelStab R package.
- 3 July 2026
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 54 (9) , 100358
Breaking the 1% unbound threshold: An IQ consortium whitepaper on the evaluation of plasma protein binding of highly bound compounds
- 3 July 2026
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 54 (9) , 100358
Breaking the 1% unbound threshold: An IQ consortium whitepaper on the evaluation of plasma protein binding of highly bound compounds
- Open Access
- 18 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2328
Combining Engineering Precision with Clinical Relevance: A Novel Dual Framework for Assessing Pedicle Screw Accuracy in Spine Surgery
Background/Objectives: Accurate pedicle screw placement is critical in spine surgery, as malposition can cause neurological, vascular, or visceral injuries and compromise construct stability. The primary objective of this study was to develop and experimentally validate a dual quantitative framework for assessing pedicle screw placement accuracy, combining (1) coaxiality, a standardized geometric metric of trajectory alignment, and (2) pedicle wall distance (dpw), a novel parameter defined as the minimal distance between the screw axis and the pedicle cortex providing surgeons with direct, millimetric, clinically actionable feedback. A secondary objective was to compare these parameters: dpw, coaxiality, entry point errors and orientation angle errors between senior surgeons and residents to evaluate the influence of surgical experience. We hypothesized that this framework would provide reproducible quantitative measurements, demonstrate strong agreement with established CBCT-based grading systems, and allow meaningful subgroup comparisons by experience level. Methods: Eight operators (four senior surgeons, four residents) performed 240 pedicle screw insertions on synthetic polyurethane lumbar spine models using freehand, CBCT-assisted, and navigation-assisted techniques. Predefined 3D trajectories were compared with actual screw positions digitized with sub-millimetric precision. Errors, coaxiality, and dpw were computed, and dpw was validated against CBCT-based Gertzbein and Heary classifications. Agreement and diagnostic performance metrics (Kappa, sensitivity, specificity) were calculated. Results: Of 236 analyzable screws, coaxiality correlated with entry point errors (ρ = 0.41), target point errors (ρ = 0.85), and orientation angle errors (ρ = 0.48), confirming its robustness as an engineering metric. dpw provided immediate, interpretable feedback and demonstrated near-perfect agreement with CBCT grading (Kappa = 0.86; sensitivity = 0.96; specificity = 0.97), detecting breaches missed by qualitative classifications. Subgroup analyses indicated small but significant differences between senior and junior surgeons for target point errors (p = 0.006), orientation angle errors (p = 0.025), and coaxiality (p = 0.023), whereas entry point errors (p = 0.201) and dpw (p = 0.163) did not differ significantly. Conclusions: This dual-metric framework bridges engineering rigor and intraoperative applicability. Coaxiality supports reproducible research assessment, while dpw enables actionable surgical feedback. The framework allows objective comparison across operators of different experience levels. Together, these metrics offer a standardized, clinically relevant, and quantitative method for evaluating pedicle screw placement, with potential to enhance surgical safety, education, and patient outcomes.
- 18 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2328
Open AccessCombining Engineering Precision with Clinical Relevance: A Novel Dual Framework for Assessing Pedicle Screw Accuracy in Spine Surgery
Background/Objectives: Accurate pedicle screw placement is critical in spine surgery, as malposition can cause neurological, vascular, or visceral injuries and compromise construct stability. The primary objective of this study was to develop and experimentally validate a dual quantitative framework for assessing pedicle screw placement accuracy, combining (1) coaxiality, a standardized geometric metric of trajectory alignment, and (2) pedicle wall distance (dpw), a novel parameter defined as the minimal distance between the screw axis and the pedicle cortex providing surgeons with direct, millimetric, clinically actionable feedback. A secondary objective was to compare these parameters: dpw, coaxiality, entry point errors and orientation angle errors between senior surgeons and residents to evaluate the influence of surgical experience. We hypothesized that this framework would provide reproducible quantitative measurements, demonstrate strong agreement with established CBCT-based grading systems, and allow meaningful subgroup comparisons by experience level. Methods: Eight operators (four senior surgeons, four residents) performed 240 pedicle screw insertions on synthetic polyurethane lumbar spine models using freehand, CBCT-assisted, and navigation-assisted techniques. Predefined 3D trajectories were compared with actual screw positions digitized with sub-millimetric precision. Errors, coaxiality, and dpw were computed, and dpw was validated against CBCT-based Gertzbein and Heary classifications. Agreement and diagnostic performance metrics (Kappa, sensitivity, specificity) were calculated. Results: Of 236 analyzable screws, coaxiality correlated with entry point errors (ρ = 0.41), target point errors (ρ = 0.85), and orientation angle errors (ρ = 0.48), confirming its robustness as an engineering metric. dpw provided immediate, interpretable feedback and demonstrated near-perfect agreement with CBCT grading (Kappa = 0.86; sensitivity = 0.96; specificity = 0.97), detecting breaches missed by qualitative classifications. Subgroup analyses indicated small but significant differences between senior and junior surgeons for target point errors (p = 0.006), orientation angle errors (p = 0.025), and coaxiality (p = 0.023), whereas entry point errors (p = 0.201) and dpw (p = 0.163) did not differ significantly. Conclusions: This dual-metric framework bridges engineering rigor and intraoperative applicability. Coaxiality supports reproducible research assessment, while dpw enables actionable surgical feedback. The framework allows objective comparison across operators of different experience levels. Together, these metrics offer a standardized, clinically relevant, and quantitative method for evaluating pedicle screw placement, with potential to enhance surgical safety, education, and patient outcomes.
- Open Access
- 13 June 2025
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 114 (8) , 103873
Predictive stability in biopharmaceuticals and vaccines: Perspectives and recommendations towards accelerating patient access
- 13 June 2025
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 114 (8) , 103873
Open AccessPredictive stability in biopharmaceuticals and vaccines: Perspectives and recommendations towards accelerating patient access
- Open Access
- 18 January 2025
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 1-9
A lyophilised formulation of chimpanzee adenovirus vector for long-term stability outside the deep-freeze cold chain
Background The adenovirus-vaccine platform has come to prominence with the COVID-19 vaccination campaigns. The objective of this study was to validate a formulation that was suitable for lyophilisation and long-term storage at 5 (2–8) °C. Methods Vaccine stability was assessed up to five years at 5 °C using a lyophilised formulation of the chimpanzee-adenovirus vector ChAd155 encoding a respiratory syncytial virus (RSV) antigen. Vaccine potency was assessed by functional infectivity assay. Other assessments of vaccine stability included those for capsid integrity, particle content, and DNA release. Vaccine efficacy and safety were assessed after two years in a murine model of RSV challenge and a rabbit toxicology model, respectively. Results Here, we show that the potency loss from lyophilisation was 0.12 log10. The potency loss over five years at 5 °C was estimated at 0.21 log10 (95%CI 0.10–0.30). This coincides with a 25% increase in the ratio of non-infectious particles/infectious particles. After two years of storage at 5 °C, (i) the loss of infectivity was 0.17 log10; (ii) the vaccine remained immunogenic and effective at clearing RSV from the lungs in a mouse-challenge model; and (iii) the vaccine was not associated with any adverse safety signal in a rabbit toxicology model. Conclusions The 5-year stability of the lyophilised adenovirus-vector vaccine is within our acceptable limit ( < 0.3 log10 decrease). Its formulation process is amenable to manufacturing scale-up and should help in providing adenovirus-based vaccines where the cold chain is problematic, such as in low-income countries, and in pre-epidemic stockpiling.
- 18 January 2025
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 1-9
Open AccessA lyophilised formulation of chimpanzee adenovirus vector for long-term stability outside the deep-freeze cold chain
Background The adenovirus-vaccine platform has come to prominence with the COVID-19 vaccination campaigns. The objective of this study was to validate a formulation that was suitable for lyophilisation and long-term storage at 5 (2–8) °C. Methods Vaccine stability was assessed up to five years at 5 °C using a lyophilised formulation of the chimpanzee-adenovirus vector ChAd155 encoding a respiratory syncytial virus (RSV) antigen. Vaccine potency was assessed by functional infectivity assay. Other assessments of vaccine stability included those for capsid integrity, particle content, and DNA release. Vaccine efficacy and safety were assessed after two years in a murine model of RSV challenge and a rabbit toxicology model, respectively. Results Here, we show that the potency loss from lyophilisation was 0.12 log10. The potency loss over five years at 5 °C was estimated at 0.21 log10 (95%CI 0.10–0.30). This coincides with a 25% increase in the ratio of non-infectious particles/infectious particles. After two years of storage at 5 °C, (i) the loss of infectivity was 0.17 log10; (ii) the vaccine remained immunogenic and effective at clearing RSV from the lungs in a mouse-challenge model; and (iii) the vaccine was not associated with any adverse safety signal in a rabbit toxicology model. Conclusions The 5-year stability of the lyophilised adenovirus-vector vaccine is within our acceptable limit ( < 0.3 log10 decrease). Its formulation process is amenable to manufacturing scale-up and should help in providing adenovirus-based vaccines where the cold chain is problematic, such as in low-income countries, and in pre-epidemic stockpiling.
- Open Access
- 25 April 2024
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 44 (5) , 293-301
Differential Utility Losses in Herpes Zoster Cases Between Vaccinated and Unvaccinated Subjects: A Meta-analysis of Three Clinical Trials
Background and Objective Recombinant zoster vaccine (RZV) is approved in adults for the prevention of herpes zoster. The effect of RZV in moderating the severity of breakthrough cases of herpes zoster has been noted but not explicitly quantified before. In this study, a meta-analysis was undertaken to estimate differential utility losses between unvaccinated (Placebo) and vaccinated (RZV) subjects in breakthrough cases of herpes zoster from three RZV clinical trials. Methods Differential utility losses between the two groups were estimated in units of quality-adjusted life-years (QALYs), leveraging aggregate patient data from the ZOE-50 (NCT01165177), ZOE-70 (NCT01165229), and ZOE-HSCT (NCT01610414) clinical trials. Differential utility losses and the ratio of mean utility losses were analyzed using random-effects and fixed-effects meta-regression models. Results The mean QALY loss differences between the unvaccinated (Placebo) and vaccinated (RZV) groups were 0.008, 0.004, and 0.011 in the ZOE-50, ZOE-70, and ZOE-HSCT studies, respectively, yielding an overall estimated difference of 0.007 (95% confidence interval 0.002–0.012) QALYs. Quality-adjusted life-year loss in the vaccinated group was estimated to be 35.5% of the value in the placebo group. A sensitivity analysis estimated an overall difference of 0.005 (95% confidence interval 0.001–0.009) QALYs, corresponding to 48.6% of the QALY loss value in the placebo group. Conclusions Recombinant zoster vaccine is effective in alleviating disease severity in breakthrough cases of herpes zoster. The results may be useful in distinguishing QALY losses between vaccinated and unvaccinated cohorts in health economics studies, particularly cost-effectiveness analyses.
- 25 April 2024
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 44 (5) , 293-301
Open AccessDifferential Utility Losses in Herpes Zoster Cases Between Vaccinated and Unvaccinated Subjects: A Meta-analysis of Three Clinical Trials
Background and Objective Recombinant zoster vaccine (RZV) is approved in adults for the prevention of herpes zoster. The effect of RZV in moderating the severity of breakthrough cases of herpes zoster has been noted but not explicitly quantified before. In this study, a meta-analysis was undertaken to estimate differential utility losses between unvaccinated (Placebo) and vaccinated (RZV) subjects in breakthrough cases of herpes zoster from three RZV clinical trials. Methods Differential utility losses between the two groups were estimated in units of quality-adjusted life-years (QALYs), leveraging aggregate patient data from the ZOE-50 (NCT01165177), ZOE-70 (NCT01165229), and ZOE-HSCT (NCT01610414) clinical trials. Differential utility losses and the ratio of mean utility losses were analyzed using random-effects and fixed-effects meta-regression models. Results The mean QALY loss differences between the unvaccinated (Placebo) and vaccinated (RZV) groups were 0.008, 0.004, and 0.011 in the ZOE-50, ZOE-70, and ZOE-HSCT studies, respectively, yielding an overall estimated difference of 0.007 (95% confidence interval 0.002–0.012) QALYs. Quality-adjusted life-year loss in the vaccinated group was estimated to be 35.5% of the value in the placebo group. A sensitivity analysis estimated an overall difference of 0.005 (95% confidence interval 0.001–0.009) QALYs, corresponding to 48.6% of the QALY loss value in the placebo group. Conclusions Recombinant zoster vaccine is effective in alleviating disease severity in breakthrough cases of herpes zoster. The results may be useful in distinguishing QALY losses between vaccinated and unvaccinated cohorts in health economics studies, particularly cost-effectiveness analyses.
- Open Access
- 23 September 2020
- Published by Wiley in Statistics in Medicine
- Vol. 39 (28) , 4334-4349
To tolerate or to agree: A tutorial on tolerance intervals in method comparison studies with BivRegBLS R Package
The well‐known agreement interval by Bland and Altman is extensively applied in method comparison studies. Two clinical measurement methods are considered interchangeable if their differences are not clinically significant. The agreement interval is commonly applied to assess the spread of the differences. However, this interval is approximate (too narrow) and several authors propose calculating a confidence interval around each bound. This article demonstrates that this approach is misleading, awkward, and confusing. On the other hand, tolerance intervals are exact and can include a confidence level if needed. Tolerance intervals are also easier to calculate and to interpret. Real data sets are used to illustrate the tolerance intervals with the R package BivRegBLS under normal or log‐normal assumptions. Furthermore, it is also explained how to assess the coverage probabilities of the tolerance intervals with simulations.
- 23 September 2020
- Published by Wiley in Statistics in Medicine
- Vol. 39 (28) , 4334-4349
Open AccessTo tolerate or to agree: A tutorial on tolerance intervals in method comparison studies with BivRegBLS R Package
The well‐known agreement interval by Bland and Altman is extensively applied in method comparison studies. Two clinical measurement methods are considered interchangeable if their differences are not clinically significant. The agreement interval is commonly applied to assess the spread of the differences. However, this interval is approximate (too narrow) and several authors propose calculating a confidence interval around each bound. This article demonstrates that this approach is misleading, awkward, and confusing. On the other hand, tolerance intervals are exact and can include a confidence level if needed. Tolerance intervals are also easier to calculate and to interpret. Real data sets are used to illustrate the tolerance intervals with the R package BivRegBLS under normal or log‐normal assumptions. Furthermore, it is also explained how to assess the coverage probabilities of the tolerance intervals with simulations.
- 30 March 2020
- Published by Elsevier
- p. 431-463
The Essentials on Linear Regression, ANOVA, General Linear and Linear Mixed Models for the Chemist
- 30 March 2020
- Published by Elsevier
- p. 431-463
The Essentials on Linear Regression, ANOVA, General Linear and Linear Mixed Models for the Chemist
- Open Access
- 28 October 2019
- Published by Wiley in Statistics in Medicine
- Vol. 38 (30) , 5603-5622
Confidence, prediction, and tolerance in linear mixed models
The literature about Prediction Interval (PI) and Tolerance Interval (TI) in linear mixed models is usually developed for specific designs, which is a main limitation to their use. This paper proposes to reformulate the two‐sided PI to be generalizable under a wide variety of designs (one random factor, nested and crossed designs for multiple random factors, and balanced or unbalanced designs). This new methodology is based on the Hessian matrix, namely, the inverse of (observed) Fisher Information matrix, and is built with a cell mean model. The degrees of freedom for the total variance are calculated with the generalized Satterthwaite method and compared to the Kenward‐Roger's degrees of freedom for fixed effects. Construction of two‐sided TIs are also detailed with one random factor, and two nested and two crossed random variables. An extensive simulation study is carried out to compare the widths and coverage probabilities of Confidence Intervals (CI), PIs, and TIs to their nominal levels. It shows excellent coverage whatever the design and the sample size are. Finally, these CIs, PIs, and TIs are applied to two real data sets: one from orthopedic surgery study (intralesional resection risk) and the other from assay validation study during vaccine development.
- 28 October 2019
- Published by Wiley in Statistics in Medicine
- Vol. 38 (30) , 5603-5622
Open AccessConfidence, prediction, and tolerance in linear mixed models
The literature about Prediction Interval (PI) and Tolerance Interval (TI) in linear mixed models is usually developed for specific designs, which is a main limitation to their use. This paper proposes to reformulate the two‐sided PI to be generalizable under a wide variety of designs (one random factor, nested and crossed designs for multiple random factors, and balanced or unbalanced designs). This new methodology is based on the Hessian matrix, namely, the inverse of (observed) Fisher Information matrix, and is built with a cell mean model. The degrees of freedom for the total variance are calculated with the generalized Satterthwaite method and compared to the Kenward‐Roger's degrees of freedom for fixed effects. Construction of two‐sided TIs are also detailed with one random factor, and two nested and two crossed random variables. An extensive simulation study is carried out to compare the widths and coverage probabilities of Confidence Intervals (CI), PIs, and TIs to their nominal levels. It shows excellent coverage whatever the design and the sample size are. Finally, these CIs, PIs, and TIs are applied to two real data sets: one from orthopedic surgery study (intralesional resection risk) and the other from assay validation study during vaccine development.
- 19 June 2017
- Published by Springer Nature in European Spine Journal
- Vol. 26 (11) , 2917-2926
Pedicle screw insertion accuracy in terms of breach and reposition using a new intraoperative cone beam computed tomography imaging technique and evaluation of the factors associated with these parameters of accuracy: a series of 695 screws
Purpose The goals of this study were to assess the accuracy of pedicle screw insertion using an intraoperative cone beam computed tomography (CBCT) system, and to analyze the factors potentially influencing this accuracy. Methods Six hundred and ninety-five pedicle screws were inserted in 118 patients between October 2013 and March 2016. Screw insertion was performed using 2D-fluoroscopy or CBCT-based navigation. Accuracy was assessed in terms of breach and reposition. All the intraoperative CBCT scans, done after screw insertion, were reviewed to assess the accuracy of screw placement using two established classification systems: Gertzbein and Heary. Generalized linear mixed models were used to model the odds (95% CI) for a screw to lead to a breach according to the independent variables. Results The breach rate was 11.7% using the Gertzbein classification and 15.4% using the Heary classification. Seventeen screws (2.4%) were repositioned intraoperatively. The only factor affecting statistically the odds to have a breach was the indication of surgery. The patients with non-degenerative disease had a significantly higher risk of breach than those with degenerative disease. Conclusion Use of intraoperative CBCT as 2D-fluoroscopy or coupled with a navigation system for pedicle screw insertion is accurate in terms of breach occurrence and reposition. However, these rates depend on the classification or grading system used. Use of a navigation system does not decrease the risk of breach significantly. And the risk of breach is higher in non-degenerative conditions (trauma, scoliosis, infection, and malignancy disease) than in degenerative diseases.
- 19 June 2017
- Published by Springer Nature in European Spine Journal
- Vol. 26 (11) , 2917-2926
Pedicle screw insertion accuracy in terms of breach and reposition using a new intraoperative cone beam computed tomography imaging technique and evaluation of the factors associated with these parameters of accuracy: a series of 695 screws
Purpose The goals of this study were to assess the accuracy of pedicle screw insertion using an intraoperative cone beam computed tomography (CBCT) system, and to analyze the factors potentially influencing this accuracy. Methods Six hundred and ninety-five pedicle screws were inserted in 118 patients between October 2013 and March 2016. Screw insertion was performed using 2D-fluoroscopy or CBCT-based navigation. Accuracy was assessed in terms of breach and reposition. All the intraoperative CBCT scans, done after screw insertion, were reviewed to assess the accuracy of screw placement using two established classification systems: Gertzbein and Heary. Generalized linear mixed models were used to model the odds (95% CI) for a screw to lead to a breach according to the independent variables. Results The breach rate was 11.7% using the Gertzbein classification and 15.4% using the Heary classification. Seventeen screws (2.4%) were repositioned intraoperatively. The only factor affecting statistically the odds to have a breach was the indication of surgery. The patients with non-degenerative disease had a significantly higher risk of breach than those with degenerative disease. Conclusion Use of intraoperative CBCT as 2D-fluoroscopy or coupled with a navigation system for pedicle screw insertion is accurate in terms of breach occurrence and reposition. However, these rates depend on the classification or grading system used. Use of a navigation system does not decrease the risk of breach significantly. And the risk of breach is higher in non-degenerative conditions (trauma, scoliosis, infection, and malignancy disease) than in degenerative diseases.